Austria vs Belgium: HICP - Tea, mate and other plant-derived products for infusion (ND)
Austria
0.6
in 2026
Belgium
0.84
in 2026
Austria rank
20th
Belgium rank
18th
HICP - Tea, mate and other plant-derived products for infusion (ND) over time
- Austria
- Belgium
How they compare
Belgium currently reports 0.84 against 0.6 in Austria, a difference of 0.24.
That makes Belgium's figure about 1.4 times Austria's.
The two have swapped places 1 time across 31 shared years of data; in 1996 it was Austria ahead.
Austria ranks 20th and Belgium ranks 18th of 27 countries.
Across the 4 decades both report, Austria averaged higher in 2 and Belgium in 2.
Head to head by decade
| Decade | Austria | Belgium | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 1.27 | 0 | 1.27 | Austria |
| 2000s | 1.03 | 0.58 | 0.446 | Austria |
| 2010s | 0.808 | 1.16 | 0.353 | Belgium |
| 2020s | 0.7657 | 1.09 | 0.3243 | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hicp - tea, mate and other plant-derived products for infusion (nd), Austria or Belgium?
- Belgium, at 0.84 against 0.6 in Austria as of 2026.
- What is the difference in hicp - tea, mate and other plant-derived products for infusion (nd) between Austria and Belgium?
- 0.24, with Belgium ahead.
- How many years of comparable data are there for Austria and Belgium?
- 31 years are reported by both, from 1996 to 2026.
- How do Austria and Belgium rank globally for hicp - tea, mate and other plant-derived products for infusion (nd)?
- Austria ranks 20th and Belgium ranks 18th of 27 countries.
- Where does this data come from?
- European Central Bank, published as HICP - Tea, mate and other plant-derived products for infusion (ND) (Neither seasonally nor working day adjusted, Sub-index weight). Statizoid refreshes it automatically from the source and publishes the full history for both places.